ASCO: The Two Sides of Gene Patenting | GenomeWeb

At the American Society for Clinical Oncology meeting in Chicago this week, oncologists gathered at a panel on gene patenting to learn more about the subject and how it might affect their work. Session chair Kenneth Offit of the Memorial Sloan-Kettering Cancer Center asked the audience how many thought gene patenting should be stopped, and nearly everyone in the room raised their hands.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Diversity Needed

Hidden Away

The Mosaic Question

This Week in Science

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.